Yanan Kong

4.0k total citations · 2 hit papers
78 papers, 2.8k citations indexed

About

Yanan Kong is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Yanan Kong has authored 78 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Cancer Research, 30 papers in Oncology and 29 papers in Molecular Biology. Recurrent topics in Yanan Kong's work include MicroRNA in disease regulation (13 papers), Cancer-related molecular mechanisms research (12 papers) and Breast Cancer Treatment Studies (10 papers). Yanan Kong is often cited by papers focused on MicroRNA in disease regulation (13 papers), Cancer-related molecular mechanisms research (12 papers) and Breast Cancer Treatment Studies (10 papers). Yanan Kong collaborates with scholars based in China, United States and Hong Kong. Yanan Kong's co-authors include Hailin Tang, Xiaoming Xie, Xinhua Xie, Lu Yang, Weidong Wei, Jiaoli Guo, Yutian Zou, Ning Lyu, Xiaojia Huang and Jin Wang and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Yanan Kong

78 papers receiving 2.8k citations

Hit Papers

The Single‐Cell Landscape of Intratumoral Heterogeneity a... 2022 2026 2023 2024 2022 2022 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Single‐Cell Landscape of Intratumoral Heterogeneity and The Immunosuppressive Microenvironment in Liver and Brain Metastases of Breast Cancer
    2022 191 citations Yutian Zou, Feng Ye et al. Advanced Science profile →
  2. N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer
    2022 167 citations Yutian Zou, Shaoquan Zheng et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanan Kong China 28 1.7k 1.3k 699 499 272 78 2.8k
Lixia Xu China 30 1.6k 1.0× 966 0.7× 622 0.9× 399 0.8× 265 1.0× 106 2.8k
Yin Sun China 35 3.1k 1.9× 1.6k 1.2× 758 1.1× 724 1.5× 122 0.4× 116 4.2k
Hongping Xia China 37 3.2k 1.9× 2.4k 1.8× 683 1.0× 604 1.2× 149 0.5× 97 4.5k
Francesco Dituri Italy 23 1.4k 0.9× 692 0.5× 788 1.1× 272 0.5× 474 1.7× 62 2.5k
Olivier Dormond Switzerland 33 1.7k 1.0× 584 0.4× 1.1k 1.6× 323 0.6× 146 0.5× 72 3.3k
Jung Woo Eun South Korea 31 2.3k 1.4× 1.2k 0.9× 502 0.7× 280 0.6× 262 1.0× 89 3.3k
Josefa Castillo Spain 20 946 0.6× 512 0.4× 683 1.0× 331 0.7× 352 1.3× 55 2.1k
Cristina Quintavalle Italy 34 2.4k 1.4× 1.8k 1.3× 369 0.5× 252 0.5× 85 0.3× 80 3.5k
Hua Ye China 27 1.7k 1.0× 1.2k 0.9× 481 0.7× 452 0.9× 56 0.2× 136 2.8k
Takeshi Tominaga Japan 24 1.3k 0.8× 987 0.7× 1.1k 1.6× 284 0.6× 124 0.5× 82 2.6k

Countries citing papers authored by Yanan Kong

Since Specialization
Citations

This map shows the geographic impact of Yanan Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanan Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanan Kong more than expected).

Fields of papers citing papers by Yanan Kong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanan Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanan Kong. The network helps show where Yanan Kong may publish in the future.

Co-authorship network of co-authors of Yanan Kong

This figure shows the co-authorship network connecting the top 25 collaborators of Yanan Kong. A scholar is included among the top collaborators of Yanan Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanan Kong. Yanan Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kong, Yanan, et al.. (2025). FOXO4-DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53-serine 15 phosphorylation. Communications Biology. 8(1). 299–299. 1 indexed citations
3.
4.
5.
Tan, Yeru, Jingping Yuan, Hailin Tang, et al.. (2024). circLIFR-007 reduces liver metastasis via promoting hnRNPA1 nuclear export and YAP phosphorylation in breast cancer. Cancer Letters. 592. 216907–216907. 23 indexed citations
6.
Zheng, Jie, Mingshuang Wang, Liwei Pang, et al.. (2024). Identification of a novel DEC-205 binding peptide to develop dendritic cell-targeting nanovaccine for cancer immunotherapy. Journal of Controlled Release. 373. 568–582. 16 indexed citations
7.
Li, Qi, Yanan Kong, Yue Zhang, et al.. (2023). A novel membrane-based integrated process for baicalin recovery from TCM Pudilan wastewater. Journal of Water Process Engineering. 53. 103868–103868. 6 indexed citations
8.
Tian, W. H., Yuhui Tang, Yanan Kong, et al.. (2023). Novel Implication of the Basement Membrane for Breast Cancer Outcome and Immune Infiltration. International Journal of Biological Sciences. 19(5). 1645–1663. 20 indexed citations
9.
Zou, Yutian, Feng Ye, Yanan Kong, et al.. (2022). The Single‐Cell Landscape of Intratumoral Heterogeneity and The Immunosuppressive Microenvironment in Liver and Brain Metastases of Breast Cancer. Advanced Science. 10(5). e2203699–e2203699. 191 indexed citations breakdown →
10.
Zou, Yutian, Shaoquan Zheng, Xinhua Xie, et al.. (2022). N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer. Nature Communications. 13(1). 2672–2672. 167 indexed citations breakdown →
11.
Yang, Anli, Weikai Xiao, Shaoquan Zheng, et al.. (2021). Predictive Nomogram of Subsequent Liver Metastasis After Mastectomy or Breast-Conserving Surgery in Patients With Nonmetastatic Breast Cancer. Cancer Control. 28. 1149432682–1149432682. 5 indexed citations
12.
Liu, Peng, Hailin Tang, Jiali Wu, et al.. (2018). Linc01638 Promotes Tumorigenesis in HER2+ Breast Cancer. Current Cancer Drug Targets. 19(1). 74–80. 7 indexed citations
13.
Xie, Xiaoming, Yanan Kong, Hailin Tang, et al.. (2014). Targeted BikDD Expression Kills Androgen-Dependent and Castration-Resistant Prostate Cancer Cells. Molecular Cancer Therapeutics. 13(7). 1813–1825. 12 indexed citations
14.
Tang, Hailin, Min Deng, Yunyun Tang, et al.. (2013). miR-200b and miR-200c as Prognostic Factors and Mediators of Gastric Cancer Cell Progression. Clinical Cancer Research. 19(20). 5602–5612. 145 indexed citations
15.
Li, Laisheng, Bo Wang, Dong Wang, et al.. (2013). Microrna-124 targets flotillin-1 to regulate proliferation and migration in breast cancer. Molecular Cancer. 12(1). 163–163. 101 indexed citations
16.
Zheng, Shan, Qingkun Song, Yu Ren, et al.. (2013). The Characteristics of Breast Cancer Subtypes. Applied immunohistochemistry & molecular morphology. 22(5). 383–389. 6 indexed citations
17.
18.
Wu, Minqing, Weidong Wei, Xiangsheng Xiao, et al.. (2012). Expression of SIRT1 is associated with lymph node metastasis and poor prognosis in both operable triple-negative and non-triple-negative breast cancer. Medical Oncology. 29(5). 3240–3249. 72 indexed citations
19.
Li, Laisheng, Xinhua Xie, Min Liu, et al.. (2012). Targeted Expression of miR-34a Using the T-VISA System Suppresses Breast Cancer Cell Growth and Invasion. Molecular Therapy. 20(12). 2326–2334. 88 indexed citations
20.
Xie, Xinhua, Jiaoli Guo, Yanan Kong, et al.. (2011). Targeted expression of Escherichia coli purine nucleoside phosphorylase and Fludara® for prostate cancer therapy. The Journal of Gene Medicine. 13(12). 680–691. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lixia Xu Breakdown of academic impact, for papers by Yin Sun Breakdown of academic impact, for papers by Hongping Xia Breakdown of academic impact, for papers by Francesco Dituri Breakdown of academic impact, for papers by Olivier Dormond Breakdown of academic impact, for papers by Jung Woo Eun Breakdown of academic impact, for papers by Josefa Castillo Breakdown of academic impact, for papers by Cristina Quintavalle Breakdown of academic impact, for papers by Hua Ye Breakdown of academic impact, for papers by Takeshi Tominaga
Rankless by CCL
2026